Cargando…
Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients
Intestinal microecology plays an important role in the development and progression of hematological malignancies. However, characteristics of gut microbiota in diffuse large B cell lymphoma (DLBCL) have not been reported. The microbiota composition of fecal samples from 25 untreated DLBCL patients a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076791/ https://www.ncbi.nlm.nih.gov/pubmed/33927704 http://dx.doi.org/10.3389/fmicb.2021.646361 |
_version_ | 1783684758129082368 |
---|---|
author | Yuan, Li Wang, Wei Zhang, Wei Zhang, Yan Wei, Chong Li, Jingnan Zhou, Daobin |
author_facet | Yuan, Li Wang, Wei Zhang, Wei Zhang, Yan Wei, Chong Li, Jingnan Zhou, Daobin |
author_sort | Yuan, Li |
collection | PubMed |
description | Intestinal microecology plays an important role in the development and progression of hematological malignancies. However, characteristics of gut microbiota in diffuse large B cell lymphoma (DLBCL) have not been reported. The microbiota composition of fecal samples from 25 untreated DLBCL patients and 26 healthy volunteers was examined by 16S rRNA gene sequencing. On α-diversity analysis, there was no significant difference in species diversity and abundance between the two groups. However, a significant difference was observed on β-diversity analysis. The intestinal microbiota in patients with DLBCL showed a continuous evolutionary relationship, which progressed from phylum, proteobacteria, to genus, Escherichia-Shigella. Their abundance was significantly higher than that of the control group. At the genus level, Allisonella, lachnospira, and Roseburia were more abundant in patients with DLBCL than in the control group. Functional prediction by PICRUSt indicated that thiamine metabolism and phenylalanine, tyrosine, and tryptophan biosynthesis were significantly lower in the DLBCL group than in the control group. In conclusion, our results clearly demonstrate that the gut microbiota was changed significantly in DLBCL. The study highlights fundamental differences in the microbial diversity and composition of patients with DLBCL and paves the way for future prospective studies and microbiome-directed interventional trials to improve patient outcomes. |
format | Online Article Text |
id | pubmed-8076791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80767912021-04-28 Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients Yuan, Li Wang, Wei Zhang, Wei Zhang, Yan Wei, Chong Li, Jingnan Zhou, Daobin Front Microbiol Microbiology Intestinal microecology plays an important role in the development and progression of hematological malignancies. However, characteristics of gut microbiota in diffuse large B cell lymphoma (DLBCL) have not been reported. The microbiota composition of fecal samples from 25 untreated DLBCL patients and 26 healthy volunteers was examined by 16S rRNA gene sequencing. On α-diversity analysis, there was no significant difference in species diversity and abundance between the two groups. However, a significant difference was observed on β-diversity analysis. The intestinal microbiota in patients with DLBCL showed a continuous evolutionary relationship, which progressed from phylum, proteobacteria, to genus, Escherichia-Shigella. Their abundance was significantly higher than that of the control group. At the genus level, Allisonella, lachnospira, and Roseburia were more abundant in patients with DLBCL than in the control group. Functional prediction by PICRUSt indicated that thiamine metabolism and phenylalanine, tyrosine, and tryptophan biosynthesis were significantly lower in the DLBCL group than in the control group. In conclusion, our results clearly demonstrate that the gut microbiota was changed significantly in DLBCL. The study highlights fundamental differences in the microbial diversity and composition of patients with DLBCL and paves the way for future prospective studies and microbiome-directed interventional trials to improve patient outcomes. Frontiers Media S.A. 2021-04-13 /pmc/articles/PMC8076791/ /pubmed/33927704 http://dx.doi.org/10.3389/fmicb.2021.646361 Text en Copyright © 2021 Yuan, Wang, Zhang, Zhang, Wei, Li and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Yuan, Li Wang, Wei Zhang, Wei Zhang, Yan Wei, Chong Li, Jingnan Zhou, Daobin Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title | Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title_full | Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title_fullStr | Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title_full_unstemmed | Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title_short | Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients |
title_sort | gut microbiota in untreated diffuse large b cell lymphoma patients |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076791/ https://www.ncbi.nlm.nih.gov/pubmed/33927704 http://dx.doi.org/10.3389/fmicb.2021.646361 |
work_keys_str_mv | AT yuanli gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT wangwei gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT zhangwei gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT zhangyan gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT weichong gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT lijingnan gutmicrobiotainuntreateddiffuselargebcelllymphomapatients AT zhoudaobin gutmicrobiotainuntreateddiffuselargebcelllymphomapatients |